The growing demand for controlled immunological study and therapeutic design has spurred significant progress in recombinant cytokine production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently produced using various expression systems, including prokaryotic hosts, higher cell lines, and baculovirus replication